Bad KOL data is expensive: Harnessing high-quality data for biopharma innovation As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data - and the costs of bad data - can help to avoid significant financial risks and missed oppor...

#marketinsights #pharmainsights #healthcareinsights #pharmastrategy #healthcarestrategy #KOLdata #engagementstrategies #patientoutcomes #biopharmas #AI #medicalengagement #HCPs #highprescribingHCPs #prescribingbehaviour #KOLeducation #clinicaltrialrecruitment
pharmaphorum.com/sales-market...

Bad KOL data is expensive: Harnessing high-quality data for biopharma innovation As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data - and the costs of bad data - can help to avoid significant financial risks and missed oppor...

As #biopharmas increasingly rely on #AI and advanced data-driven technologies, evaluating the quality of #data - and the costs of bad data - can help to avoid significant financial risks and missed opportunities.

pharmaphorum.com/sales-market...

Fast-Tracking Development: How Life Sciences Will Drive Speed in 2025 Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed across product development with an emphasis on getting new treatments in the hands of doctors and patient...

#Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed across #productdevelopment with an emphasis on getting new treatments in the hands of doctors and patients.

#pharma #pharmaceutical #regulatory #marketaccess #strategy